Your browser doesn't support javascript.
loading
Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.
Strefford, J C; Kadalayil, L; Forster, J; Rose-Zerilli, M J J; Parker, A; Lin, T T; Heppel, N; Norris, K; Gardiner, A; Davies, Z; Gonzalez de Castro, D; Else, M; Steele, A J; Parker, H; Stankovic, T; Pepper, C; Fegan, C; Baird, D; Collins, A; Catovsky, D; Oscier, D G.
Afiliación
  • Strefford JC; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Kadalayil L; Genetic Epidemiology and Bioinformatics, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Forster J; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Rose-Zerilli MJ; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Parker A; Department of Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Lin TT; CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Heppel N; CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Norris K; CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Gardiner A; Department of Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Davies Z; Department of Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Gonzalez de Castro D; Haemato-oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Else M; Haemato-oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Steele AJ; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Parker H; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Stankovic T; Division of Cancer Sciences, School of Medicine, University of Birmingham, Birmingham, UK.
  • Pepper C; CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Fegan C; CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Baird D; CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Collins A; Genetic Epidemiology and Bioinformatics, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Catovsky D; Haemato-oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Oscier DG; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Leukemia ; 29(12): 2411-4, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26256637
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Linfocítica Crónica de Células B / Telómero Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Linfocítica Crónica de Células B / Telómero Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article